Representation of Kitov Pharma Ltd. in a US$35M registered direct offering of shares represented by American Depositary Shares (ADSs) and warrants to purchase ADSs.
H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering.
Kitov Pharma Ltd. (NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create successful long-lasting treatments for people with cancer.
